GAIP ASD Research Study
NCT07622316
This study is recruiting at 2 US sites in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This clinical research study evaluates the safety and preliminary effects of AdiaVita (umbilical cord blood-derived stem cells and exosomes) combined with glutathione versus glutathione alone in people aged 3 and older with Autism Spectrum Disorder (ASD).
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autism Spectrum Disorder
- Autism
- ASD
- Autism Spectrum Disorder (ASD)
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 3 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Sponsor
- Greater Atlanta Integrative Pediatrics
- Last updated on ClinicalTrials.gov
- June 3, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Georgia · 2
- Greater Atlanta Integrative Pediatrics · Roswell, GA
- Greater Atlanta Integrative Pediatrics · Roswell, GA
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.